Erastapex trio 20 mg / 5 mg / 12.5 mg 30 tablets

Tradename

Erastapex trio

Erastapex trio

Composition

Each tablet contains:

Olmesartan medoxomil 20 mg

Amlodipine 5 mg

Hydrochlorothiazide 12.5 mg

Auxiliary components:

Mannitol, crospovidone, polyvinyl purrolidone, sodium lauryl sulfate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate.

Properties

This is a combined drug that includes an angiotensin II receptor antagonist (olmesartan medoxomil), a thiazide diuretic (hydrochlorothiazide) and amlodipine besylate, a calcium channel blocker. The combination of these three active substances has a synergistic effect and helps to lower blood pressure to a greater extent than each active ingredient separately, has a combined antihypertensive effect, as a result of which blood pressure decreases to a greater extent than when each of them is taken separately. When taking the drug once a day, an effective and uniform decrease in blood pressure is achieved within 24 hours.

Indications

— essential arterial hypertension

The drug is indicated for patients in whom monotherapy with olmesartan medoxomil or amlodipine does not provide the necessary control of blood pressure.

Method of administration and dosage:

Contraindications

— severe arterial hypotension;

-shock (including cardiogenic shock);

— violation of the outflow of blood from the left ventricle (for example, with severe aortic stenosis);

Side effects

From the side of the central nervous system:

Often: dizziness.

Uncommon: syncope.